🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
To assess the levels of loteprednol etabonate (LE) in tear fluid following ...
Status
Completed
Location
Bausch & Lomb Research Clinic
Start Date
2013-01
Trial ID
NCT01736527
Treatments Being Tested
The objective of this study is to evaluate the safety and efficacy of lotep...
Status
Completed
Location
Bausch & Lomb Incorporated
Start Date
2014-09
Trial ID
NCT02208297
Treatments Being Tested
Loteprednol Etabonate Ophthalmic Gel, (BID and TID) versus Vehicle Group fo...
Status
Completed
Location
Valeant Site 01
Start Date
2016-06
Trial ID
NCT02786901
Graft rejection has traditionally been one of the leading causes of cornea ...
Status
Completed
Location
Price Vision Group
Start Date
2013-03
Trial ID
NCT01853696
Treatments Being Tested
Patients are already receiving an intravitreal injection as a standard of c...
Status
Completed
Location
Vistar Eye Center
Start Date
2022-12-22
Trial ID
NCT05542381
Treatments Being Tested
The objective of this study is to identify any adverse events or adverse dr...
Status
Completed
Location
Bausch & Lomb Korea Ltd
Start Date
2010-08-05
Trial ID
NCT01437982
Treatments Being Tested
This study compared the ocular tolerability of fluorometholone acetate opht...
Status
Completed
Location
Williamson Eye Center
Start Date
2021-05-01
Trial ID
NCT07588074
Treatments Being Tested
Corneal haze, in which the cornea becomes cloudy, is a well-known and a pot...
Status
Completed
Location
Moran Eye Center - Midvalley Location
Start Date
2014-09-19
Trial ID
NCT03123614
Treatments Being Tested
The objective of this study is to evaluate the safety and efficacy of lotep...
Status
Completed
Location
Bausch & Lomb Incorporated
Start Date
2013-12
Trial ID
NCT01996839
Treatments Being Tested
Evaluation of the Safety, Systemic Pharmacokinetics, and Tolerability of Si...
Status
Completed
Location
Valeant Site 01
Start Date
2015-02
Trial ID
NCT03063489
Treatments Being Tested